secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evoke Pharma Inc (—)
CIK:        0001403708
Form:       8-K
Filed at:   2023-11-22T23:59:59+00:00
Accession:  0000950170-23-065881
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Evoke Pharma receives Nasdaq delisting notice for failure to meet minimum equity requirement
--------------------------------------------------------------------------------

- Received delisting notice from Nasdaq on Nov 21, 2023 for non-compliance with minimum stockholders' equity of $2.5M.
- Previously granted extension until Nov 20, 2023 to regain compliance; failed to do so.
- Company plans to timely request a hearing before Nasdaq Hearings Panel to stay delisting.
- Actively exploring options to regain compliance, including raising additional capital.
- No assurance that hearing will grant continued listing or that compliance can be achieved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1403708/000095017023065881/0000950170-23-065881-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1403708/000095017023065881/evok-20231121.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-065881

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer